Hypertension Diagnostics, Inc. operates in the Surgical and medical instruments sector. Hypertension Diagnostics, Inc. engaged in design, development, manufacture and marketing of devices that non-invasively measure both large and small artery elasticity. The Company's product provides cardiovascular parameters. The Company markets three products: CVProfilor DO-2020 CardioVascular Profiling System, HDI/PulseWaveCR-2000 Research CardioVascular Profiling System and CVProfilor MD-3000 CardioVascular Profiling System. The CVProfilor DO-2020 System is being marketed to care physicians and other health care professionals within the United States. These physicians and other health care professionals can purchase the CVProfilor DO-2020 directly from it, lease it through a third-party capital lease, or rent it from the Company on a per-patient-tested rental basis. Utilizing its Central Data Management Facility (CDMF), it tracks utilization of the CVProfilor DO-2020 System in each physician's office and medical clinic. In
our complete report available for purchase the company is compared to: Biomimetic Therapeutics, Inc., Daxor Corporation and Tearlab Corporation.